
Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …
NHS England has pulled the plug on a £50 million fund to advance innovation in the investigation and treatment of …
The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

